Main navigation

Resources

Tools, Information, and Publications

Members of the McGill International TB Centre have developed some tools and resources:

Tools

Cost and Human Resource Calculator for COVID-19 Testing

This website contains a calculator to estimate the costs and the number of administrative, healthcare, and laboratory personnel required to perform active COVID-19 testing using RT-PCR of high-risk populations, as well as tools to estimate sample size necessary to estimate SARS-CoV-2 prevalence in these populations and the frequency of repeat testing.

Visit the webpage.

Quality of TB Care – eBook

The McGill International TB Centre, Mayo Clinic Center for Tuberculosis and the TBPPM Learning Network are pleased to present a new eBook on Quality of Tuberculosis Care. This free eBook, edited by Professors Madhukar Pai & Zelalem Temesgen is a compilation of a series on Quality of TB Care, published in the Journal of Clinical Tuberculosis & Other Mycobacterial Diseases.

The BCG World Atlas Second Edition - Updated in 2017

A Database of Global BCG Vaccination Policies and Practices - http://bcgatlas.org/

The first of its kind, the BCG World Atlas is a database of policies and practices of the Bacillus Calmette-Guérin (BCG) vaccine, the only licensed vaccine for tuberculosis (TB) from countries all over the world.

The Online TST/IGRA Interpreter

This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of ≥5mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23) and/or a commercial Interferon Gamma release assay (IGRA) - www.tstin3d.com

TB skin test training for Health care workers:

YouTube Video: English https://www.youtube.com/watch?v=l5aXERzu9zs

YouTube Video: French https://www.youtube.com/watch?v=mcz8-fiMbJw

YouTube Video: Portuguese https://www.youtube.com/watch?v=k8_v0xIM1d4

YouTube Video: Vietnamien https://www.youtube.com/watch?v=r2g_TlIYj-0

YouTube Video: Bahasa: https://www.youtube.com/watch?v=_A7D4NrI7dI

PowerPoint Presentation: English Tuberculin Skin Testing TST Technique Training

PowerPoint Presentation: French Formation sur l’injection IntraDermo- Réaction à la tuberculine (IDR)

Introducing N-TB, an app for nutritional assessment & counselling of patients with tuberculosis

The WHO India recommends that nutritional assessment, counseling and support should be an integral part of TB care. Several actions such as guidance documents for patients, support via food rations, and even direct monetary benefits are being implemented. These initiatives require healthcare providers to be skilled in nutritional assessment and counseling. The first app of its kind, N-TB enables the classification of the nutritional status of the patient, gives alerts in case of severe undernutrition and provides management solutions based on the patient's local context.

Undernutrition is a common co-morbidity in patients with active TB, which has serious implications for the outcomes of treatment. It is a risk factor for early death during treatment, drug-induced hepatotoxicity, poor performance status at end of treatment and relapse of disease after successful treatment. Nutritional assessment, counselling and support are now considered as integral part of therapy of patients with TB.

Download the free App in Google Play

MycoHit Software

Graphical user interface for Genomic Sequence Comparison
MycoHit is a JAVA application: https://www.mcgill.ca/molepi/mycohit-software

Containment Level 3 (CL3) TB Facility Core Director: Dr. Marcel Behr Containment Level 3

The Facility for TB research meets the highest safety standards defined by Canadian guidelines (PHAC and CFIA). Work carried out in this facility includes all experimental procedures involving the manipulation of live Mycobacterium tuberculosis. The facility is available to RI-MUHC researchers, affiliated collaborators and external researchers working on tuberculosis.

DATABASE available to members of the TB Centre:
"Understanding the keys to tuberculosis: from exposure to infection, and from infection to disease".
This database was established from 2006 to 2012 from questionnaires and biologic samples.

Information

Public–private mix for TB prevention and care: a roadmap

First-ever targeted WHO roadmap outlines steps to scale-up public-private health sector engagement to end TB

The PLOS Tuberculosis Channel

You may have already heard about the PLOS Tuberculosis Channel, a global forum for tuberculosis related research, curated by Dr. Soumya Swaminathan and Dr. Madhukar Pai. It’s a place to stay updated on news, discussion and commentary in the field. But have you explored all the content the Channel has to offer and subscribed to updates? https://channels.plos.org/tuberculosis

The TBDx Pathway

The first ever web-based pathway for tuberculosis (TB) diagnostics (Dx) and adjunct technologies www.tbdxpathway.org

QuTUB Quality of Tuberculosis care

www.qutubproject.org

In this new public community on GHDonline, professionals ranging from clinicians, policy-makers, researchers, implementers, and advocates share questions, successes, and lessons learned to advance the field of global health diagnostics. https://www.ghdonline.org/diagnostics/

Resources for TB diagnostics developers: TB Frequently Asked Questions

TB Diagnostics: Top 10 FAQs By Test Developers - http://www.tbfaqs.org/

Evidence-Based TB Diagnosis

A Comprehensive Resource For Evidence Syntheses, Policies, Guidelines and Research Agendas On TB Diagnostics - http://tbevidence.org/

A website for learning and teaching epidemiology -

http://www.teachepi.org/

Publications

TB Stigma Measurement Guidance

Click here for brochure

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis

McGill Research influences WHO TB policies

WHO has just released new clinical guidelines for treatment of INH-resistant TB (based in part on the work of Dr Dick Menzies and others at McGill, Montreal). Isoniazid-resistant TB, without concurrent rifampicin resistance, is estimated to occur in about 8% of people with TB globally. A regimen of 6 months rifampicin, ethambutol, pyrazinamide and levofloxacin is now recommended in adults and children diagnosed with this type of drug-resistant TB. Resistance to rifampin and fluoroquinolones should be ruled out before using this regimen.
Read more

Nature Reviews Disease PrimerTuberculosis - with over 47,000 downloads!

Within the 99th percentile (ranked 762nd) of 252,738 tracked articles of a similar age in all journals

Within the 95th percentile (ranked 1st) of 24 tracked articles of a similar age in Nature Reviews Disease Primers

An international group of top TB experts from several leading institutions, coordinated by the McGill International TB Centre, published a primer on tuberculosis (TB) in the journal Nature Reviews Disease Primers. View here

Let's Talk TB - 3rd Edition (2018)

Let's Talk TB is a book on the current best practices in TB diagnosis and treatment available for free for all GPs and private practitioners in India and other high-burden countries.

Click here for free download: www.letstalktb.org/